Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological therapeutics, announced today that the first set of ...

Alan Kohler has been a financial journalist for 46 years. He began as a cadet on The Australian covering the Poseidon boom and bust; has been a columnist for Chanticleer in the Australian ...